. 2024 Dec 13;6(50):1331–1336. doi: 10.46234/ccdcw2024.264

Table 2. Immune responses to different hepatitis B vaccination regimens in chronic kidney disease patients in China from May 2019 to February 2020.

Response	IM_0-1-620 (n=71)*	IM_0-1-220 (n=75)*	IM_0-1-260 (n=78)*
Note: group with * or ^† indicates no significant differences between two groups (P>0.05); group with ^† and * indicates significant differences between two groups (P<0.05). Abbreviation: CKD=chronic kidney disease; GMC=geometric mean concentration; CI=confidence interval.
GMC, mIU/mL (95% CI)	1,675.2 (866.1, 2,484.4)*	280.2 (170.9, 389.5)^†	824.1 (86.38, 1,561.8)*
Seroconversion rate, % (95% CI)	81.7 (71.2, 89.0)	77.3 (66.7, 85.3)	88.5 (79.5, 93.8)
High-response rate, % (95% CI)	69.0 (57.5, 78.6)*	44.0 (33.3, 55.3)^†	64.1 (53.0, 73.9)*